ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38535 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38535; 2) Community: the network communities that were significantly associated with the response to NSC 38535; 3) Molecule: the relationships between components within communities and NSC 38535; 4) MDR: the compounds that were significantly associated with the NSC 38535.

NSC Compound Enrichment Correlation
NSC 699666 Null 5.49145982993963e-005 0.70724282
NSC 639504 Cyclopentanone, 2-[(dimethylamino)methyl]-5-octylidene-, hydrochloride 6.0696584370492e-006 0.62920861
NSC 704286 Null 6.0696584370492e-006 0.6761939
NSC 131233 Cyclopentanone, 2,5-bis[(dimethylamino)methyl]-, dihydrochloride 6.10737882231376e-006 0.82958421
NSC 30637 Null 7.8300773712716e-007 0.66921833
NSC 10660 Null 8.12512419150683e-005 0.2566642
NSC 698280 Null 8.12512419150697e-005 0.68678154
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 9.15580043872279e-005 0.77595403
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 9.15580043872279e-005 0.6847507
NSC 682824 Propanimidoyl chloride, N-[[[(3-chloro-4-fluorophenyl) amino]carbonyl]oxy]-2-methyl- 9.15580043872288e-005 0.76909948
Total:121  Current:120    [First] [Prev] [Next] [Last]